![Thomas Boesen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Boesen
Geschäftsführer bei
SYNACT PHARMA AB
Vermögen: 446 250 $ am 31.05.2026
Profil
Thomas Boesen was the founder of TXP Pharma GmbH.
Current job included Chief Operating Officer at SynAct Pharma AB since 2021.
Former jobs include Director-Drug Discovery at EpiTherapeutics ApS, Principal at Lica Pharmaceuticals A, and Vice President-Discovery at Action Pharma A. Education includes a graduate degree from The University of Edinburgh, graduate and doctorate degrees from the University of Copenhagen, and a graduate degree from Roskilde University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SYNACT PHARMA AB 0,44 % | 31.12.2024 | 236 529 ( 0,44 % ) | 446 250 $ | 31.05.2026 |
Aktive Positionen von Thomas Boesen
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNACT PHARMA AB | Geschäftsführer | 26.01.2021 |
Ehemalige bekannte Positionen von Thomas Boesen
| Unternehmen | Position | Ende |
|---|---|---|
TXP Pharma GmbH | Gründer | - |
Lica Pharmaceuticals A/S
 Lica Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services | Corporate Officer/Principal | - |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Corporate Officer/Principal | - |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Thomas Boesen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lica Pharmaceuticals A/S
Lica Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services | Commercial Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Roskilde University
 Roskilde University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiTherapeutics ApS
EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
TXP Pharma GmbH |
